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Fibrous dysplasia is a benign skeletal disorder in which the normal bone and marrow are replaced by fibrous tissue 
and haphazardly distributed woven bone. The aim of this case report is to discuss the orthodontic treatment of a 
13-year-old patient with fibrous dysplasia in the left maxilla. The patient had rotated maxillary second premolars, 
moderate crowding in both maxillary and mandibular arches with low maxillary frenal attachment. Orthodontic 
treatment was done with full fixed appliance and extraction of maxillary and mandibular third molars. Maxillary 
frenectomy and free gingival graft in mandibular anterior region were performed by a periodontist. The oral and 
maxillofacial surgery team monitored fibrous dysplasia in the left maxilla on a yearly interval. There is very limited 
information about orthodontic management of patients with craniofacial fibrous dysplasia. This case report discus-
ses the orthodontic treatment and the importance of interdisciplinary approach in the management of patient with 
maxillofacial fibrous dysplasia.




Fibrous dysplasia (FD), first described by Lichtenstein 
in 1938, is a benign skeletal disorder in which the nor-
mal bone and marrow are replaced by fibrous tissue and 
haphazardly distributed woven bone (1). When it invol-
ves one bone, it is termed as Monostotic FD (MFD) and 
polyostotic FD (PFD) when it involves multiple bones. 
Patients with PFD may have McCune-Albright syndro-
me (MAS), which is the triad of PFD, café-au-lait skin 
macules, endocrinopathies and precocious puberty (2). 
Mutations in the α subunit of the stimulatory G protein 
encoded by the gene GNAS has been described as the 
etiology of FD (3).
Craniofacial bones, proximal femur and ribs are the 
most frequent and common locations of FD (4, 5). Zygo-
matic-maxillary complex is reported to be the most com-
monly involved bone in MFD (6) and the craniofacial 
region is involved in almost 90% of cases of PFD (7). 
The signs and symptoms vary depending on the location 
of FD. If it involves the craniofacial bones, it can result 
in facial deformity, asymmetry and malocclusion. If the 
cranial base is involved, it can result in vision changes, 
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hearing impairment, nasal obstruction, pain, or paresthe-
sia (8). The most common characteristic of radiographic 
appearance is ‘ground glass’ of mixed radiolucency/opa-
city (9).
The differential diagnosis for craniofacial FD can be 
extensive.  The patient’s history, growth characteristics 
of the lesion and radiographic examination are all im-
portant in narrowing the differential diagnosis.  Other 
fibro-osseous lesions (ossifying fibroma, cemento-os-
sifying fibroma, cemento-osseous dysplasia, giant cell 
granuloma, and both aneurysmal and simple bone cysts) 
can be included in a broad differential diagnosis (8). 
Furthermore Paget’s disease, osteosarcoma and chronic 
sclerosing osteomyelitis should fall in the differential 
diagnosis for craniofacial FD (8,10). Rapidly chan-
ging, symptomatic, or extremely painful lesions require 
biopsy, if possible, as these may indicate a more aggres-
sive FD, or a different serious diagnosis (3). Quiescent 
(unchanging) or asymptomatic lesions may not require 
biopsy with sufficient history, examination and radiogra-
phy (3). In its quiescent or non-aggressive forms, FD is 
often discovered during routine dental examination or 
orthodontic evaluation. This case report discusses the 




A Caucasian female, 13 years 7 months of age, presen-
ted to the orthodontic clinic with chief complaint of “my 
canines are hurting and lower teeth are crooked.” A de-
tailed dental, medical, and social history was obtained 
from the patient and patient’s parent. Patient had inci-
pient secondary sex characteristics and had started me-
narche 2 years ago (her mother also had her menarche 
at the same age). The patient’s canine stage was H with 
apical foramen closed and cervical vertebral maturation 
(CVMS) stage 3 with 10-25% adolescent growth remai-
ning. Her mother reported to have had similar malocclu-
sion and patient reported of frequent headaches.
-Assessment
The clinical examination showed lip competence at re-
pose, posterior divergent face with slightly increased fa-
cial convexity, obtuse nasolabial angle, decreased lower 
facial third, and retruded lower lip (Fig. 1). Patient had 
Class I molar and Class II canine relationship on right 
and Class III molar and Class II canine relationship on 
left with retrusive upper incisors and both overbite and 
overjet of 4mm. Maxillary and mandibular midline was 
on with MSP (midsagittal plane) and rotated maxillary 
second premolars were present in addition to 1.4mm 
and 5.2mm crowding in maxillary and mandibular arch. 
Posterior buccal crossbite of maxillary right second 
premolar was present and decreased attached gingiva 
in mandibular canine-canine region with low maxillary 
frenal attachment was observed (Figure 1). The patient 
had generalized enamel decalcification and composite 
restoration on the mesial surfaces of maxillary lateral 
incisors (Fig. 1).
The lateral cephalometric radiograph analysis revealed 
that patient was skeletal Class II with (ANB=4.6) due to 
a retrognathic mandible (SNB=77.5) and low mandibu-
lar plane angle (SN-MP=25.7) indicating hypodivergent 
growth pattern (Fig. 1c). The maxillary incisors were 
retroclined (U1-SN=95.1), and the mandibular incisors 
had slight proclination (IMPA=94.6). Patient had an ob-
tuse nasolabial angle (110.9◦), and upper (-2.4mm) and 
lower (-1.9mm) lips were retrusive to the E-line (Fig. 
1c). The panoramic radiograph showed cloudy left maxi-
llary sinus (Fig. 1 d). The treatment was initiated and the 
patient was referred to the oral and maxillofacial surgery 
department for extraction of maxillary and mandibular 
third molars. A CT scan was obtained for further evalua-
tion of left maxillary sinus lesion.  The scan showed an 
approximately 4 cm x 3 cm lesion in the left maxillary 
sinus with ground glass appearance in addition to mild 
bony expansion of the left maxilla (Fig. 2a). This lesion 
was consistent in appearance with fibrous dysplasia of 
the maxilla. The patient and family declined biopsy of 
the lesion; however, her history, specifically lack of en-
docrinopathies, combined with clinical and radiographic 
examination were sufficient for diagnosis of FD.  At the 
time of diagnosis, the patient and family were entirely 
unaware of the lesion and mild facial asymmetry caused 
by the lesion.  After diagnosis with FD, her stage of FD 
was thought to be either quiescent (no active growth), or 
non-aggressive (slow growth) (3). Close monitoring and 
repeat CT scans at yearly intervals were performed to 
further stage her FD.  
-Treatment Objectives
The treatment objectives were to 1) resolve 1.4mm 
and 5.2mm crowding in the maxillary and mandibular 
arch and maintain transverse dimensions, 2) derotate 
maxillary second premolars, 3) correct posterior buccal 
crossbite of maxillary right second premolar, 4) main-
tain Class I molar on right, achieve Class I molar on left 
and Class I canine on both sides, 5) achieve optimum 
overbite and overjet, and 6) level the curve of spee and 
achieve ideal lip balance relative to E-plane. 
-Treatment Alternative
The alternative treatment plan was to extract upper and 
lower second premolars to resolve crowding and to ex-
tract upper and lower third molars. After discussing with 
patient, non-extraction single-phase comprehensive 
treatment using full fixed appliance was chosen primari-
ly due to lip support and profile concerns.
-Treatment Progress
Single-phase comprehensive non-extraction treatment 
(except for extraction of upper and lower third molars) 
using full fixed appliance was performed.  The overall 
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Fig. 1: (a) Pretreatment facial and intraoral photographs, (b) Pretreatment ceph-
alograph, (c) tracing, (d) panoramic radiograph showing opacification of left 
maxillary sinus region.
active treatment lasted 29 month followed by the deli-
very of upper Hawley retainer and lower bonded lingual 
retainer in 3-3 for retention.
-Following sequences of treatment was delivered:
0.022” pre-adjusted brackets (American Orthodontics 
Twin), Roth prescription were used. Oral hygiene ins-
tructions were reinforced to the patient throughout the 
treatment. 1) Bands were placed on the U/L first mo-
lars and bonded remaining teeth, placed lingual bu-
ttons on the U5s with the archwire (AW) sequence of 
0.014” NiTi, 0.016” NiTi; 0.017” x 0.025” TMA.  2) 
Elastomeric power chain to derotate U5s. 3) Changed 
AWs to 0.017”x0.025” SS, protracted UL6 mesially. 4) 
Maxillary frenectomy and free gingival graft in mandi-
bular anterior region were performed by a periodontist. 
5) After sufficient healing period, 0.019”x0.025” SS 
mandibular AW with reverse curve of Spee was pla-
ced subsequently. 6) Bonded U7’s and 0.016” NiTi; 
0.016”x0.022” NiTi as auxiliary AWs to align 7s. 7) 
Class II elastics from U3 to L6s to get canine in Class I 
relation. 8) Delivered upper Hawley and lower bonded 
lingual retainer in 3-3 after deband/debond. 
CT scans taken at yearly intervals showed no change in 
lesion size (Fig. 2 (b,c,d). 
-Treatment Results
The posttreatment records indicate that the treatment ob-
jectives were achieved. Both maxillary and mandibular 
crowding were resolved, maxillary second premolars 
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Fig. 2: (a) Computed Tomography (CT) Face 2015: Axial and coronal views. 
Arrows indicating opacification of the left maxillary sinus and bony expansion 
of left maxilla. Note the “ground glass” appearance of the FD lesion indicated 
by the arrows, (b) CT Face 2016: Axial and coronal views. Note minimal change 
from previous scan taken in 2015, (c) CT Face 2017: Axial and coronal views. 
Minimal to no change in lesion size, (d) 3Dimensional reconstruction of Figure 
2 (c). Arrows show size discrepancy between left and right maxilla due to expan-
sion from FD.
were derotated and posterior crossbite of maxillary right 
second premolars was corrected (Fig. 3a). On the right 
side, Class I canine was achieved and the molar relation 
was maintained as Class I. On the left side, Class I ca-
nine and Class I molar relation was achieved. Curve of 
Spee was leveled and optimum overbite and overjet was 
obtained resulting in ideal lip balance relative to E-plane 
(Fig. 3c). 
All three planes of maxilla were maintained since no or-
thopedics or surgery were performed and on the mandi-
ble with minimal downward growth and backward rota-
tion. On the maxillary dentition, incisors were proclined 
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Fig. 3: (a) Posttreatment facial and intraoral photographs, (b) Posttreatment ceph-
alograph, (c) tracing and (d) panoramic radiograph.
(U1-SN, from 95.1° to 105.1°). Fair vertical control of 
maxilla was observed with the maxillary incisors extru-
ded slightly and intermolar width reduced by 1.8mm. On 
the mandibular dentition, the lower incisors were procli-
ned (IMPA, from 94.6°-103.5°), overbite was reduced 
from 4mm to 2mm, intermolar and intercanine width 
were reduced by 1.1mm and 1.5 respectively. In terms 
of facial esthetics, no significant facial change was noti-
ced. No significant facial asymmetry was noticed from 
the FD. 
Discussion
Approximately 90% of patients with FD have lesions in 
craniofacial bone. This includes maxilla and mandible 
and these lesions can grow rapidly to cause expansion 
of bone and displace orbit and teeth resulting in seve-
re malocclusion and facial disfigurement (7,9,11,12). 
Maxillo-mandibular FD is also associated with dental 
development disorder from metabolic dysfunction and 
disordered bone architecture that affect tooth develo-
pment and eruption (13,14). The most common dental 
anomalies associated with FD include tooth rotation, 
oligodontia, displacement, enamel hypoplasia, enamel 
hypomineralization, taurodontism, retained deciduous 
teeth and attrition (15). Our patient had rotation of maxi-
llary second premolars (U5s) and crowding/malocclu-
sion, which can be attributed to FD. 
High caries index is indicated in patients with maxi-
llo-mandibular FD, attributed to the severe malocclu-
sion, increased enamel hypoplasia and hypomineraliza-
tion (11). Due to severe malocclusion and high caries 
index, more frequent dental recall is recommended to 
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control dental plaque accumulation. Our patient had fair 
oral hygiene throughout the treatment with high caries 
index from malocclusion and generalized white disco-
loration with discolored composite restoration in mesial 
surface of U2s, which were recommended for future res-
torative consult for better esthetics.
FD in the craniofacial skeleton, causing significant dys-
morphic features such as facial asymmetry and deformi-
ty and dental anomalies have radiographic appearance of 
radiolucency/opacity of ground glass morphology. Our 
patient was diagnosed with FD as evidenced by panora-
mic radiographs and CT scans in the left maxillary sinus 
area, which was significantly filled with FD bone tissue 
and radiopacity (Fig. 1d). This homogenous feature is 
most common during childhood and adolescence, then 
the lesions become less radiolucent, more mixed, and 
heterogeneous with age (9,11). Taurodontism seen on 
the dental radiographs may be associated with endocrine 
disorders, such as growth hormone excess, and can be 
an indicator of an underlying endocrinopathy associated 
with MAS (11,16,17).
One of most common symptom of FD is pain and adults 
are more likely to have more severe pain than children, 
suggesting that there is an age-related increase in the 
prevalence of pain (18). Bisphosphonates have been mo-
derately effective in pain management, but no effect has 
been found to alter the disease course (19). More recently 
Denosumab, a monoclonal antibody to Receptor activa-
tor of nuclear factor kappa-Β ligand (RANKL), has been 
explored as a medical treatment for FD resulting in the 
reduction in bone pain, tumor growth, and bone turnover 
markers (20). Another study has examined Tocilizumab, 
a monoclonal antibody to Interleukin-6 (IL-6), and have 
found it may be effective in treating bone pain refractory 
to bisphosphonate therapy (21). Regardless, there are still 
no accepted medical treatments for curing or stopping the 
progression of the disease (19-21). One of our patient’s 
chief concern was pain in the canine area and this can be 
due to the FD, which is located in the left maxillary sinus, 
and pressure can attribute to the pain in the area. 
Surgical treatment for patients with craniofacial FD 
should be individualized to each patient. If patients are 
satisfied with their appearance and their FD is quies-
cent or non-aggressive, watchful waiting is deemed to 
be an acceptable form of treatment (3). In patients with 
visual disturbance or patients who are unsatisfied with 
their appearance, surgery is the most accepted treatment 
modality (22). Certain authors recommend conservative 
therapy, which involves recontouring the bone to restore 
normal bony shape (22). Advantages of this therapy is 
that it is relatively non-invasive and is easily accepted 
by patients; however need for re-operation is higher with 
conservative treatment (23). Other surgical groups lean 
towards radical excision of the lesion with immediate 
reconstruction, if possible.(6) This method has a lower 
incidence of re-operation and has curative potential; 
however, this method does have increased comorbidi-
ty due to the more extensive surgery (23). Our patient 
was monitored by yearly CT scan for two years after the 
initial diagnosis and her FD appeared to be in a quies-
cent stage (Fig. 2b,c).  The patient and family elected to 
forego surgery and are following up at regular intervals 
for monitoring.  
Reports in the literature so far indicate that patients with 
FD do not require special dental management and were 
able to undergo routine dental care safely and successfu-
lly without exacerbation and complication of FD lesions 
(3,24). The reported procedures included dental restora-
tion, tooth extraction, orthodontic therapy, odontoma re-
moval, maxillary cyst removal and biopsy of jaws (16). 
However, due to having access to very few and smaller 
patient pool, the limited data on effectiveness and out-
come of dental procedures in maxillo-mandibular FD/
MAS patients of current clinical challenges faced by 
dental anomalies of FD/MAS patient is unclear (25). In 
our case, patient preferred not to do any extractions for 
the orthodontic treatment and her treatment did not have 
any effect on her FD lesion even after extracting all third 
molars during the treatment.
In addition, literature reported among the patients that 
received orthodontic therapy, the duration of treatment 
appeared to take longer than normal (2-4 years) and 
the results were less satisfactory and there was relapse 
(3,16). One theory reported more rapid orthodontic too-
th movement in FD involved bone but, data to support 
this is currently lacking (8). The duration of treatment 
for our patient was within normal time frame and no 
significant delay in treatment was found in relevance to 
the FD and satisfactory results were delivered for the or-
thodontic treatment and maxillary Hawley retainer and 
lower lingual bonding retainers on 3-3 were delivered to 
prevent relapse.
It is advised to delay orthodontic therapy till after age of 
skeletal maturity based on patients’ needs and outcomes 
of orthodontic evaluation since FD disease activity de-
creases after skeletal maturity (8). Our patient initiated 
treatment at CVMS 3 (Fig. 1b) when peak in mandibular 
growth has already occurred and because of possible re-
lapse on the U5s after orthodontic treatment, patient was 
referred to periodontist for circumferential supracrestal 
fibrotomy procedure for prevention of relapse. 
Conclusions
The goal of management in craniofacial FD is to mainly 
focus on the improvement of function and esthetics. In 
this report, the patient diagnosed with FD had successful 
orthodontic treatment. For, MAS/FD, the dental profes-
sional must be able to recognize characteristic signs of 
FD and be able to work in a team with other medical 
colleagues to develop appropriate treatment strategies. 
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